Your left-hand grip strength is one of the most powerful predictors of your future health that almost nobody measures. In a study of nearly 140,000 adults across 17 countries, grip strength predicted death from any cause more accurately than systolic blood pressure. Every 5 kg drop in grip was linked to a 16% higher risk of dying over the next four years, regardless of age, sex, income level, or country of origin.
What makes this test unusual is its simplicity. You squeeze a handheld device as hard as you can, and the number it produces reflects far more than hand strength. Grip strength tracks closely with the strength of your entire body, your muscle mass, your metabolic health, and even the health of your heart and brain. It is, in effect, a single number that captures how well your body is aging.
When you squeeze a dynamometer, the reading depends on the coordinated effort of dozens of muscles in your forearm and hand. These muscles are built from contractile proteins (actin and myosin) that shorten on demand, structural proteins (like titin) that maintain fiber architecture, and energy systems that fuel the contraction. But the test is not really measuring your hand. It is sampling a much larger system.
Grip strength correlates with total body muscle mass, the proportion of lean tissue relative to fat, and the quality of the signals running from your brain through your nerves to your muscles. It also reflects your inflammatory status: higher levels of inflammatory molecules like IL-6 and TNF-alpha are consistently associated with weaker grip. In this way, a single squeeze captures information about muscle biology, nervous system function, metabolic health, and systemic inflammation all at once.
The connection between grip strength and cardiovascular disease is among the best-studied in all of preventive medicine. In the UK Biobank, a study of over 500,000 adults followed for about 7 years, each 5 kg decrease in grip strength increased cardiovascular death risk by 19% in women and 22% in men after adjusting for age, lifestyle, and existing health conditions. Adults classified as having muscle weakness had roughly 20% higher odds of developing coronary heart disease or atrial fibrillation.
A European study tracking over 20,000 adults across 12 countries for 13 years found that people in the strongest quarter of grip had 36% lower rates of heart disease compared to the weakest quarter. In women, the protection was even greater at 46%. These associations held up after accounting for physical activity, body weight, and pre-existing conditions.
Low grip strength is linked to higher cancer death rates, though the relationship varies by cancer type. In the UK Biobank, each 5 kg decrease in grip was associated with 17% higher colorectal cancer mortality and 24% higher breast cancer mortality in women. A separate analysis of over 445,000 UK Biobank participants found that those with the strongest grip relative to their body size had lower risk of endometrial cancer (24% lower), liver cancer (19% lower), and kidney cancer (11% lower).
No significant association was found between grip strength and prostate cancer risk, suggesting that the protective relationship is not uniform across all cancer types.
Grip strength, particularly when adjusted for body weight, is a strong predictor of diabetes risk. A meta-analysis found that each 0.1 increase in relative grip strength (your grip divided by your body weight) was associated with 22% lower diabetes risk. This outperformed absolute grip strength, which showed only a 5% risk reduction per 5 kg increase. The distinction matters: a person who is strong for their size is metabolically healthier than someone who is simply strong.
In a Korean study of nearly 28,000 adults, those in the weakest quarter of relative grip strength had roughly 3 times the odds of having diabetes compared to the strongest quarter. Men in the weakest group had 2.7 times higher risk, and women had 3.4 times higher risk.
A 2026 meta-analysis of 94 cohort studies found that adults with the highest grip strength had 43% lower odds of cognitive decline, 38% lower odds of dementia, and 30% lower odds of depression compared to those with the weakest grip. These associations were independent of age, physical activity, and other health conditions. The mechanism likely involves shared biological pathways between muscle and brain health, including inflammation and metabolic signaling.
Grip strength varies dramatically by sex, age, and body size. Peak strength occurs in the 30s to 40s and declines steadily after that. The left hand is typically 2 to 5 kg weaker than the dominant right hand in right-handed individuals. Because this test measures in pounds, the reference values below have been converted accordingly. These ranges are drawn from large population studies; your own trend over time matters more than any single cutpoint.
| Category | Men (approximate) | Women (approximate) |
|---|---|---|
| Peak strength (ages 30 to 40) | ~112 lb (51 kg) | ~68 lb (31 kg) |
| Low strength (sarcopenia screening) | <59 lb (<27 kg) | <35 lb (<16 kg) |
| Weakness (frailty criteria) | Population-specific lowest quintile | Population-specific lowest quintile |
European and American guidelines use slightly different thresholds. The EWGSOP2 sarcopenia guideline defines low grip as below 27 kg for men and below 16 kg for women. A German study of over 200,000 adults suggested slightly higher cutpoints of 29 kg for men and 18 kg for women. Mortality risk begins to climb meaningfully at about half a standard deviation below the average for your age and sex. At age 60, that degree of weakness was associated with 3.0 fewer years of life in men and 1.4 fewer years in women.
For mortality risk specifically, dose-response analyses show that the benefit of higher grip strength plateaus around 42 kg (93 lb) in men and 25 kg (55 lb) in women. Beyond those levels, additional strength does not appear to reduce mortality further.
A single grip strength reading tells you where you stand right now, but the real value emerges when you track changes over time. Your grip naturally declines with age, but the rate of that decline varies enormously between people. Detecting an accelerated drop, one that is faster than expected for your age, can flag problems like emerging sarcopenia, worsening inflammation, or declining metabolic health long before they show up on standard lab work.
The test has excellent repeatability, with test-retest reliability scores above 0.92. However, meaningful change requires a shift of roughly 5 kg (about 11 lb) to confidently say something has changed beyond normal day-to-day variation. When measured annually, a change of about 20% in your result is needed to indicate a real shift rather than noise.
Get a baseline measurement now, especially if you are over 40 or have any risk factors for muscle loss. If you are starting a new exercise program or making dietary changes aimed at preserving muscle, retest in 3 to 6 months to see whether the intervention is working. After that, measure at least annually. If your number drops by more than 5 kg between readings, treat that as a signal to investigate further rather than waiting for the next annual check.
Time of day affects your result. Grip strength is lowest in the morning and highest in the evening, with a difference of about 1 kg (2.2 lb) between the two. If you are tracking trends, try to test at roughly the same time of day each time.
Acute illness and inflammation temporarily suppress grip. Even mild inflammation (elevated CRP) can reduce your reading by about 1.6 kg, and moderate inflammation can drop it by over 3 kg. If you have been sick, wait until you are fully recovered before testing. Surgery has an even larger effect: hospitalized patients lose significant grip strength, with readings remaining depressed for weeks to months after a procedure.
Technique matters more than most people realize. At least three maximal squeezes should be performed, since up to 37% of people do not produce their best effort on the first attempt. Rest for at least 15 seconds between attempts and use the highest value. Body position (seated versus standing) and elbow angle also affect the number, so keep these consistent between sessions.
Reduced kidney function can independently lower grip strength. If your estimated kidney filtration rate (eGFR) is below 60, your grip may be lower than expected regardless of your actual muscle health. Kidney function measured by cystatin C shows a stronger relationship with grip than creatinine-based estimates, likely because creatinine itself is influenced by muscle mass.
Evidence-backed interventions that affect your Grip Strength (Left) level
Grip Strength (Left) is best interpreted alongside these tests.